Here, this study reveals that the high level of IL4I1 promoted immune escape and predicted poor prognosis in thyroid cancer, which provides direction for future research into the novel target for immunotherapy, and diagnostic and unfavorable prognostic biomarker. Here, IL4I1 is linked to thyroid gland carcinoma.